HCV Patients Face Obstacles to Treatment
by
Washington Correspondent, MedPage Today
Washington Correspondent, MedPage Today
Barriers include high-cost prices, restrictive state regulations
WASHINGTON -- Hepatitis C virus (HCV) patients, and particularly those on Medicare and Medicaid, continue to battle for access to curative treatments and coverage of those therapies, according to participants at a briefing on Capitol Hill on Tuesday.
The briefing was sponsored by The AIDS Institute, a nonprofit that advocates for patients with HIV and HCV. The session was billed as "An Update on Hepatitis C In the United States," and speakers included a CDC official, a representative of the the Centers for Medicare and Medicaid Services (CMS), and others
Continue reading....
The briefing was sponsored by The AIDS Institute, a nonprofit that advocates for patients with HIV and HCV. The session was billed as "An Update on Hepatitis C In the United States," and speakers included a CDC official, a representative of the the Centers for Medicare and Medicaid Services (CMS), and others
Continue reading....
No comments:
Post a Comment